Genomics | WekaIO

overview

Weka allows Genomics England to scale to extreme performance and capacity in their mandate to sequence 5 million genomes by 2023.

Genomics England (GEL) aims to sequence 5 million genomes from National Health Service (NHS) patients with rare diseases. A team of over 3,000 researchers use the DNA data acquired from NHS for medical research. GEL expects the data to grow to over 140 Petabytes by 2023. The research conducted requires access to the entire data set and must allow researchers to query the data in a highly randomized fashion. Therefore, all data has to be stored in a single storage system.

“We needed something that’s much more scalable than existing NAS solutions — an infrastructure that could grow to hundreds of petabytes. Our existing solution couldn’t provide that scale and wasn’t performing as well in these magnitudes — that’s what drove us to Weka”.

David Ardley, Director of Infrastructure Transformation

Challenge

In 2018, Genomics England approved a new storage platform to support the projected growth to 5 million genomes by 2023. Previously, GEL had implemented a scale-out NAS solution from a leading vendor to support the 100,000 genome project; however, it had already hit its limit on storage node scaling, and performance suffered when the system was near capacity. In addition, the existing solution had no viable disaster recovery strategy, as backing up all 21 petabytes of storage was infeasible. Key national data would be in a vulnerable position if a major disaster were to occur. The GEL infrastructure team determined that it needed a new storage strategy to support the anticipated growth through 2023.